Univariate analysis identified macrovascular invasion, intrahepatic tumor numbers > 10, alpha–fetoprotein (AFP) levels > 400 ng/mL, and CPS classes B and C as risk factors for progression, while a prior response to anti-PD-1 therapy was protective. Here, PDCD1 is linked to neoplasm.